MAP3K7 Antikörper (Thr184)
Kurzübersicht für MAP3K7 Antikörper (Thr184) (ABIN5621318)
Target
Alle MAP3K7 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- Thr184
-
Spezifität
- TAK1 antibody detects endogenous levels of total TAK1 protein
-
Kreuzreaktivität (Details)
- Mouse, Rat
-
Produktmerkmale
- Rabbit polyclonal TAK1 antibody
-
Aufreinigung
- TAK1 antibody was purified by affinity chromatography
-
Immunogen
- TAK1 antibody was raised in Rabbit using a synthesized non-phosphopeptide derived from human TAK1 around the phosphorylation site of threonine 184 (I-Q-TP-H-M) as the immunogen
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- WB: 1:500 - 1:1000, ELISA: 1:1000
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Supplied in liquid format, PBS buffer, pH 7.4, 150 mM NaCl with added preservative 0.02 % sodium azide and 50 % glycerol
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Aliquot and store at -20 deg C. Avoid repeated freeze thaw cycles
-
-
- MAP3K7 (Mitogen-Activated Protein Kinase Kinase Kinase 7 (MAP3K7))
-
Andere Bezeichnung
- TAK1
-
Pathways
- NF-kappaB Signalweg, T-Zell Rezeptor Signalweg, TLR Signalweg, Fc-epsilon Rezeptor Signalübertragung, Activation of Innate immune Response, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response, Tube Formation, Toll-Like Receptors Cascades, BCR Signaling, Ubiquitin Proteasome Pathway
Target
-